Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.350
-0.005 (-1.44%)
At close: Nov 20, 2024, 4:00 PM
0.347
-0.003 (-0.83%)
Pre-market: Nov 21, 2024, 5:46 AM EST
Enveric Biosciences Employees
Enveric Biosciences had 7 employees as of December 31, 2023. The number of employees decreased by 19 or -73.08% compared to the previous year.
Employees
7
Change (1Y)
-19
Growth (1Y)
-73.08%
Revenue / Employee
n/a
Profits / Employee
-$1,408,040
Market Cap
3.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | -19 | -73.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | 21 | 700.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareMax | 1,450 |
| iSpecimen | 53 |
| Aditxt | 47 |
| Matinas BioPharma Holdings | 32 |
| Oncternal Therapeutics | 30 |
| Palisade Bio | 9 |
| Quoin Pharmaceuticals | 4 |
| Aptorum Group | 3 |
ENVB News
- 6 days ago - Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results - Business Wire
- 8 days ago - Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002 - Business Wire
- 16 days ago - Enveric Biosciences Announces Broad Range of Patent Issuances - Business Wire
- 5 weeks ago - Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003 - Business Wire
- 2 months ago - Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop - Business Wire
- 2 months ago - Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit - Business Wire
- 2 months ago - Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 3 months ago - Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries' License for Treatment of Radiation Dermatitis and Other Conditions - Business Wire